Magnetic And Ph-Sensitive Dual Actuation Of Biohybrid Microswimmer Of Targeted Drug Release Suitable For Cancer Cell Microenvironment,
2025
DGIST Daegu
Magnetic And Ph-Sensitive Dual Actuation Of Biohybrid Microswimmer Of Targeted Drug Release Suitable For Cancer Cell Microenvironment, Richa Chaturvedi, Yumin Kang, Yunji Eom, Sri Ramulu Torati, Cheolgi Kim
Center for Bioelectronics Publications
The chemotherapeutic agents most frequently used in cancer treatment often have limited effectiveness because of their low specificity for tumors and poor therapeutic performance. In addition to the aforementioned therapeutic challenges the drug delivery carriers conjugated with the drug encounter early detection and elimination from the immune system before arriving at the affected area continues to be a significant research focus among researchers. To address this prevalent issue, an effective approach has been developed that leverages the physiological differences between normal and tumor tissue to enhance the efficacy of anticancer drugs. This drug delivery system is designed based on pH-sensitive …
Department Of Medicinal Chemistry, Virginia Commonwealth University: Historical And Personal Reflections,
2025
Virginia Commonwealth University
Department Of Medicinal Chemistry, Virginia Commonwealth University: Historical And Personal Reflections, Richard A. Glennon
VCU University History Books
This book presents a historical account of Virginia Commonwealth University's Department of Medicinal Chemistry, compiled and recollected in 2025 by Professor Emeritus Richard A. Glennon. Included are personal reflections alongside a historical overview of the department's origins and faculty, as well as newly developed programs and initiatives.
From Proposal To Podcast: Starting A Student-Driven Pharmacy Podcast In The Classroom,
2025
Belmont University
From Proposal To Podcast: Starting A Student-Driven Pharmacy Podcast In The Classroom, Jarett C. Worden, Jennifer Duck
Funded Scholarship
Background: Podcasts are a widely available and popular educational medium for healthcare providers, residents, students, and patients. Podcasts are convenient, accessible, and may be effective education tools for listeners. While some studies have attempted to measure the effectiveness of podcasting to enhance knowledge, there are few studies evaluating podcasts in pharmacy education. The purpose of this project was to provide students with the opportunity to create a podcast episode through an in-class, semester-long assignment and to evaluate student perceptions of knowledge, confidence, and professional identity.
Educational activity: Over the course of a semester-long elective class, students worked in groups to …
Artificial Intelligence In Pharmacy Education: Balancing Technological Advances And Ethical Concerns Among Aspiring Pharmacists,
2025
Department of Healthcare and Pharmaceutical Management, School of Management and Business Studies, Jamia Hamdard, Delhi-110062
Artificial Intelligence In Pharmacy Education: Balancing Technological Advances And Ethical Concerns Among Aspiring Pharmacists, Ubada Aqeel, Shibu John
Health Professions Education
Background Artificial intelligence (AI) is transforming healthcare, including pharmacy practice, by enhancing access to information, reducing errors, and supporting decision-making. However, its integration into pharmacy education remains underexplored. This study investigated pharmacy students' perceptions of AI's impact on their profession and the need for curriculum reform. Materials and Methods A cross-sectional survey was conducted among 245 Bachelor of Pharmacy (BPharm) students from Jamia Hamdard, India. Data were collected using a structured questionnaire covering knowledge, perceptions, and opinions on AI in pharmacy. Responses were analyzed using non-parametric tests, including the Mann-Whitney U and Kruskal-Wallis H tests, to examine group differences. Exploratory …
A Novel D-Peptide Modulates Dclk1 Gelsolin Interactions, Reducing Pdac Tumor Growth,
2025
University of Oklahoma Health Sciences Center
A Novel D-Peptide Modulates Dclk1 Gelsolin Interactions, Reducing Pdac Tumor Growth, Landon L. Moore, Dongfeng Qu, Parthasarathy Chandrekesan, Kamille Pitts, Randal May, Byron E. Anderson, Milton L. Brown, Courtney W. Houchen
Department of Medicine Faculty Publications
What drives inflammation-associated tumorigenesis and progression in pancreatic ductal adenocarcinoma (PDAC)? Doublecortin-like kinase 1 (DCLK1) is a central driver of inflammation-associated tumorigenesis, with elevated expression linked to worse clinical outcomes. Two isoforms of DCLK1 possess a unique extracellular domain (ECD). DCLK1 isoform 2 contains two microtubule-binding domains, while isoform 4, lacks the microtubule-binding domains but, plays a pivotal role in tumor progression. We identified novel D-peptides that selectively target this ECD, significantly suppressing PDAC cell proliferation in vitro and tumor growth in xenograft models without inducing cell death. In silico modeling and binding assays revealed DCLK1 isoform 4 interacts with …
The Short And Sweet On Sodium-Glucose Cotransporter Inhibitors And Glucagon-Like Peptide-1 Receptor Agonists In Heart Failure,
2025
University of Miami Miller School of Medicine
The Short And Sweet On Sodium-Glucose Cotransporter Inhibitors And Glucagon-Like Peptide-1 Receptor Agonists In Heart Failure, Jose L. Batista, Tracy Makuvire, Jonathan D. Davis, Salvatore Carbone
EVMS School of Health Professions Faculty Publications
Heart failure (HF) affects 6 million people in the US, and type 2 diabetes (T2D) is a significant risk factor for HF. Since 2008, regulatory agencies have required cardiovascular safety trials for new T2D therapies, and these have consistently demonstrated the cardiovascular benefits of glucose-lowering drugs. Sodium-glucose cotransporter inhibitors (SGLTi) and glucagon-like peptide-1 (GLP-1) receptor agonists (RAs)/glucose-dependent insulinotropic polypeptide (GIP) reduce major adverse cardiovascular events and deaths, regardless of diabetes status, and improve cardiorespiratory fitness. SGLTis, such as dapagliflozin and empagliflozin, benefit patients with reduced and preserved ejection fraction, significantly reducing HF hospitalizations and cardiovascular deaths. The DAPA-HF and EMPEROR-Reduced …
The Impact Of Non-Pharmacological Interventions As An Adjunct Initial Treatment For Chemotherapy-Induced Oral Mucositis: Reduction Of Complications,
2025
Dominican University of California
The Impact Of Non-Pharmacological Interventions As An Adjunct Initial Treatment For Chemotherapy-Induced Oral Mucositis: Reduction Of Complications, Ngoc Tran Tham
Nursing | Senior Theses
Chemotherapy-induced oral mucositis (CIOM) reflects a major complication in oncology patients undergoing chemotherapeutics. The ulcers and inflammation of the oral cavity endured by patients report severe discomfort, experience difficulties in swallowing and talking, show increased sensitivity to infection, and face extended hospitalization. Among the contributing factors might be poor dietary condition, poor medication compliance, and an overall decline in physical health. Opioid analgesics are among the medications used to treat pain. In addition to the many negative consequences, long-term opioid usage may lead to dependence and raise medical expenses. Therefore, to improve a patient's physical health and reduce the consequences …
Optimizing Endogenous Glp-1 Holistically: A Nursing Led Approach To Sustainable Weight Loss Without Glp-1 Agonist Use,
2025
Dominican University of California
Optimizing Endogenous Glp-1 Holistically: A Nursing Led Approach To Sustainable Weight Loss Without Glp-1 Agonist Use, Taylee A. Carscadden
Nursing | Senior Theses
The increase in off-label Glucagon-like peptide-1 (GLP-1) receptor agonist drugs, such as semaglutide (Ozempic), for weight loss has sparked concern in regards to the not fully understood drug outcomes and safety. GLP-1 agonists were originally developed to manage Type 2 Diabetes Mellitus, but have been widely prescribed for obesity management despite minimal research on prolonged use in non-diabetic patients. This study explores how off-label use of GLP-1 agonist drugs exacerbate various adverse health outcomes, highlighting gastrointestinal complications, and the very possible dependency on drugs for weight management. It will also examine the efficacy of nursing-led education on the implementation of …
Medical-Grade Honey And Standard Dressings In Burn Wound Care: Evaluating Effectiveness, Cost, And Patient Outcomes,
2025
Dominican University of California
Medical-Grade Honey And Standard Dressings In Burn Wound Care: Evaluating Effectiveness, Cost, And Patient Outcomes, Andrew Golonka, Chloe Shin
Nursing | Senior Theses
Background: Burn injuries burden the healthcare system globally as silver sulfadiazine (SSD) is the standard treatment even though it delays healing and is highly costly. Medical-grade honey (MGH) demonstrates superior antimicrobial and anti-inflammatory properties, however, there are still evidence gaps when comparing effectiveness, cost efficiency, and patient centered outcomes. Purpose: This study aims to compare MGH and SSD amongst these gaps to inform evidence based burn care. Methods:A randomized controlled trial will enroll 100 people between 25-50 years of age with first and second degree burns, < 20% total body surface area within two hospital burn units. Participants will be assigned to either MGH or SSD treatment. The study will be a single blind design where dermatologists evaluating the wound photographs will not know the treatment given. Primary outcomes include wound healing time, infection rates, and patient reported pain scores. Secondary outcomes will focus on cost effectiveness analyses and patient quality of life. Standardized protocols will be implemented for data collection, wound assessment, and safety monitoring. Results: We anticipate that MGH will have lower infection rates, promote faster wound …
Alpha-Synuclein Interaction With Gedunin,
2025
Missouri State University
Alpha-Synuclein Interaction With Gedunin, Tony Matundura Nyabayo
Graduate Theses/Dissertations
Parkinson’s disease (PD) and other Proteinopathies develop when α-synuclein misfolds and aggregates into toxic amyloids. While existing treatments for PD are primarily focused on managing its symptoms, a viable solution for slowing down the progress of Parkinson’s disease involves targeting the toxic α-synuclein amyloids. Gedunin, a natural inhibitor of heat shock protein 90, has been extensively used to treat malaria. Also, recent research investigations have shed light on its potential beyond malaria therapy, indicating that Gedunin may offer a possible solution for treating a variety of neurodegenerative diseases. Using plate-based assays, we examined how Gedunin influences α-synuclein fibrillation and its …
Gramseq-Dta: A Grammar-Based Drug-Target Affinity Prediction Approach Fusing Gene Expression Information,
2025
Virginia Commonwealth University
Gramseq-Dta: A Grammar-Based Drug-Target Affinity Prediction Approach Fusing Gene Expression Information, Kasul Debnath, Pratip Rana, Preetam Ghosh
Computer Science Faculty Publications
Drug–target affinity (DTA) prediction is a critical aspect of drug discovery. The meaningful representation of drugs and targets is crucial for accurate prediction. Using 1D string-based representations for drugs and targets is a common approach that has demonstrated good results in drug–target affinity prediction. However, these approach lacks information on the relative position of the atoms and bonds. To address this limitation, graph-based representations have been used to some extent. However, solely considering the structural aspect of drugs and targets may be insufficient for accurate DTA prediction. Integrating the functional aspect of these drugs at the genetic level can enhance …
Use Of Finerenone For Chronic Kidney Disease In Type 2 Diabetes: A Cross-Sectional Study At A Large Health System,
2025
Parkview Health
Use Of Finerenone For Chronic Kidney Disease In Type 2 Diabetes: A Cross-Sectional Study At A Large Health System, Robert D. Beckett
Parkview Pharmacy Department
Presented at the Midyear Clinical Meeting.
While most patients met individual KDIGO finerenone initiation criteria, fewer than one-third met all guideline recommended parameters. Guideline directed K+ monitoring following initiation was underperformed, highlighting a need for improved follow up Procedures.
Evaluation And Reduction Of Pediatric Precaution Alert Volume Across A Large Community Health System,
2025
Parkview Health
Evaluation And Reduction Of Pediatric Precaution Alert Volume Across A Large Community Health System, Sarah Ferrell Pharmd
Parkview Pharmacy Department
Presented at the Midyear Clinical Meeting.
This evaluation found the potential to remove 15,174 alerts per year. Based off a physician spending a median of 8 seconds processing an alert, a reduction of 15,174 alerts per year saves about 34 hours of physician work-time per year.
One Bolus, Many Benefits: Implementing Tenecteplase For Acute Ischemic Stroke,
2025
Parkview Health
One Bolus, Many Benefits: Implementing Tenecteplase For Acute Ischemic Stroke, Robert D. Beckett Pharmd
Parkview Pharmacy Department
Presented at the Midyear Clinical Meeting.
Overall, no statistically significant differences in door-to-needle time or secondary outcomes between alteplase and tenecteplase groups was identified. This could relate to time in imaging and patient evaluation. Patients treated with tenecteplase showed greater bleeding risk versus alteplase, though these results were not statistically significant when accounting for baseline age in an exploratory regression. Patients who received tenecteplase were slightly older, on average.
Evaluation Of Terlipressin Use At A Community Health System,
2025
Parkview Health
Evaluation Of Terlipressin Use At A Community Health System, Robert D. Beckett Pharmd
Parkview Pharmacy Department
Presented at the Midyear Clinical Meeting.
Findings of this evaluation suggest opportunities to improve terlipressin utilization by sharing results back to Nephrology and GI and
reviewing P&T-approved criteria for use, implementing EMR alerts to reinforce dosing
protocols every 24-48 hours for dose adjustments
or discontinuation based on Scr trends (day 4 and
beyond), and supporting daily monitoring of fluid
and respiratory status.
Findings of this evaluation suggest opportunities to improve terlipressin utilization by sharing results back to Nephrology and GI and
reviewing P&T-approved criteria for use, implementing EMR alerts to reinforce dosing
protocols every 24-48 hours for dose adjustments
or …
Levetiracetam-Induced Acute Kidney Injury In A Pediatric Patient,
2025
Parkview Health
Levetiracetam-Induced Acute Kidney Injury In A Pediatric Patient, Makaila A. Geese Pharmd Candidate, Norm Fenn Bcps, Bcpps
Parkview Pharmacy Department
Presented at PPA Meeting.
Objective: To describe a case of acute kidney injury following levetiracetam administration in an adolescent patient.
Key takeaways:
Acute kidney injury (AKI) following levetiracetam is rare, especially in pediatric patients
Kidney injury was not correlated with supratherapeutic levetiracetam concentrations
Morganella Morganii Meningitis In A Neonate: A Case Report,
2025
Parkview Health
Morganella Morganii Meningitis In A Neonate: A Case Report, Madelin Vessels Pharmd Candiadate, Cassie Rough Pharmd Candidate, Robyn Schmucker Md, Mph, Norm Fenn Bcps, Bcpps
Parkview Pharmacy Department
Presented at Midyear Clinical Meeting
Objective: To summarize the interventions that took place to add to the limited data that exists in the world surrounding the treatment and outcomes of M. morganii infections.
Key takeaways:
- M. morganii meningitis is highly rare in neonates
- There are no defined treatment guidelines or outcomes available to date
- Cefepime sufficiently treated M. morganii meningitis, bacteremia, and concurrent E. coli urinary tract infection
Comparison Of Isoflurane To Sevoflurane In A Pediatric Patient With Refractory Status Asthmaticus: A Case Report,
2025
Parkview Health
Comparison Of Isoflurane To Sevoflurane In A Pediatric Patient With Refractory Status Asthmaticus: A Case Report, Janella Rianna N. Benitez Mba, Pharmd, Norm Fenn Bcps, Bcpps, Fashp
Parkview Pharmacy Department
Presented at Midyear Clinical Meeting.
Objective: To describe the use of inhaled anesthetics in a pediatric patient with severe, refractory status asthmaticus unresponsive to conventional therapies.
No Cap! Evaluation Of Empiric Antibiotic Duration For Community Acquired Pneumonia,
2025
Parkview Health
No Cap! Evaluation Of Empiric Antibiotic Duration For Community Acquired Pneumonia, Bailey Castato Pharmd
Pharmacy Residency
Presented at the Midyear Clinical Meeting.
This evaluation found that patients hospitalized for CAP (including severe) without culture data or with negative respiratory cultures met clinical stability criteria early in admission. The maximum time to clinical stability was approximately 5 days. However, total median antibiotic duration was 7 days (IQR 6.0- 8.7), resulting in 2 days (IQR 1.5-3.9) of excess antibiotics.
Silent Pressure: Outcomes Of As-Needed Antihypertensives In Hospitalized Adults*,
2025
Parkview Health
Silent Pressure: Outcomes Of As-Needed Antihypertensives In Hospitalized Adults*, Corey Uetrecht Pharmd Candidate
Pharmacy Residency
Presented at ACCP
This study found that PRN antihypertensives are frequently used for AEBP in hospitalized patients, despite limited benefit and potential risk of hypotension-related adverse events.
